![]() Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | ![]() LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. | ![]() Repertoire Immune Medicines Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 2004 | Founding Date 1985 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Los Angeles, US HQ | Locations Cambridge, US HQ Schlieren, CH Cambridge, US |
Employees | Employees 433% increase | Employees 194362% increase | Employees 385% decrease | Employees 887% increase |
Valuation ($) | Valuation ($) 129.4 m | Valuation ($) 515.9 m | Valuation ($) 901.1 k | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($9.7m) (FY, 2025) | Net income ($153.5m) (FY, 2025) | Net income ($1.6m) (FY, 2024) | Net income N/A |

UroGen Pharma is a clinical-stage biopharmaceutical company.
View company
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View company
Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases.
View company